Bioequivalence Study Between Two Oral Formulations of Ibuprofen 800 mg Tablets Under Fasting Conditions
NCT00804440
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Bioequivalency
Interventions
DRUG:
Ibuprofen Tablets, 800 mg
Sponsor
Perrigo Company